Study reveals how lung diseases affect Kids' arm strength and balance
NCT ID NCT07148362
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study looked at how well children with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD) can use their arms for exercise, how their muscles use oxygen, and their balance. Researchers compared 88 children aged 6-18 with CF, PCD, and healthy peers. The goal was to understand differences in these areas to guide future care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help design better exercise programs for children with CF and PCD.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot directly improve health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
88 people
The number who actually took part.
- Started
-
Jan 2021
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Thirty-one patients with CF, 27 patients with PSD were included in the study. There are 30 healthy data.
- Ages
-
6 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Cystic fibrosis patients • Patients between the ages of 6-18 years who are diagnosed with cystic fibrosis according to the American Cystic Fibrosis Association consensus report and whose clinical condition is stable will be included in the study. Primary ciliary dyskinesia patients • Patients between the ages of 6-18 years who are diagnosed with primary ciliary dyskinesia according to the American Thoracic Society (ATS) and European Respiratory Society (ERS) guidelines and whose clinical condition was stable will be included in the study. Healthy controls • Healthy individuals of both sexes between the ages of 6-18 who voluntarily agreed to participate in the study will be included. Exclusion Criteria: Patients •Patients who are uncooperative, have orthopedic or neurological disorders that will affect functional capacity, and have pneumonia or any acute infection during the evaluation will be excluded from the study. Healthy controls; •Those with a known chronic disease, uncooperative and orthopedic or neurological disorders that will affect functional capacity will not be included.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cystic fibrosis (CF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gazi University Faculty of Health Sciences Department of Physiotherapy ana Rehabilitation, Cardiopulmonary Rehabilitation Unit
Ankara, Çankaya, 06490, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Glucose sensor may flag diabetes risk in cystic fibrosis
- Can Drug-Level testing personalize cystic fibrosis treatment?
- MRI could reveal a new way to ease gut troubles in cystic fibrosis
- AI may predict lung decline in cystic fibrosis kids using muscle and balance data
- Can we spot hidden muscle loss in kids with a rare lung condition?
- Do kids with a rare lung condition face hidden muscle loss?